The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.
© Clarivate Analytics, Journal Citation Reports 2025
Journal Information
Most often read
18460
Doping and sports endocrinology: anabolic-androgenic steroidsJ.A. García-Arnés, N. García-Casares
Rev Clin Esp. 2022;222:612-20
18460
Open access
Open Article
16545
Evaluation of the efficacy of N-acetylcysteine and bromhexine compared with standard care in preventing hospitalization of outpatients with COVID-19: a double blind randomized clinical trialA. Eslami Ghayour, S. Nazari, F. Keramat, F. Shahbazi, A. Eslami-Ghayour
Rev Clin Esp. 2024;224:86-95
16545
15790
Clinical characteristics of patients hospitalized with COVID-19 in Spain: results from the SEMI-COVID-19 RegistryJ.M. Casas-Rojo, J.M. Antón-Santos, J. Millán-Núñez-Cortés, C. Lumbreras-Bermejo, J.M. Ramos-Rincón, E. Roy-Vallejo, A. Artero-Mora, F. Arnalich-Fernández, ... en nombre del Grupo SEMI-COVID-19, Network.
Rev Clin Esp. 2020;220:480-94
15790
Open access
15095
COVID-19, a worldwide public health emergencyM. Palacios Cruz, E. Santos, M.A. Velázquez Cervantes, M. León Juárez
Rev Clin Esp. 2021;221:55-61
15095
Full text access
Open Article
11487
Analysis of the expression of the Serpina1 gene in SARS-CoV-2 infection: study of a new biomarkerM. Pintanel-Raymundo, S. Menao-Guillén, J.J. Perales-Afán, A. García-Gutiérrez, I. Moreno-Gázquez, M. Julián-Ansón, M. Ramos-Álvarez, S. Olivera-González, ... M.A. Torralba-Cabeza
Rev Clin Esp. 2024;224:253-8
11487
9388
Prevalence of neutralizing antibodies against SARS-CoV-2 using a rapid serological test in health workers of a Spanish Department of Health in Alicante (Spain) before the booster dose of the vaccineA.C. Montagud, J. Llenas-García, R. Moragues, A. Pérez-Bernabeu, M.J. Alcocer Pertegal, F.J. García Gómez, A.M. Gamayo Serna, H. García Morante, ... J. Tuells
Rev Clin Esp. 2024;224:197-203
9388
Full text access
Open Article
7398
Severe cardiovascular events among spectators of Spanish professional soccer league before and after COVID-19 onsetL. Consuegra-Sánchez, J.A. Martínez
Rev Clin Esp. 2024;224:332-4
7398
7025
Recommendations for oral treatment for adult patients with type 1 Gaucher diseaseM.Á. Torralba-Cabeza, M. Morado-Arias, A. Pijierro-Amador, M.C. Fernández-Canal, J. Villarrubia-Espinosa
Rev Clin Esp. 2022;222:529-42
7025
Open access
Open Article
6959
Pulmonary embolism during SARS-CoV-2 pandemic: Clinical and radiological featuresA. García-Lledó, M. del Palacio-Salgado, C. Álvarez-Sanz, M.M. Pérez-Gil, Á. Cruz-Díaz
Rev Clin Esp. 2022;222:354-8
6959
6875
Vericiguat in heart failure: From scientific evidence to clinical practiceJ.R. González-Juanatey, M. Anguita-Sánchez, A. Bayes-Genís, J. Comín-Colet, A. García-Quintana, A. Recio-Mayoral, J.L. Zamorano-Gómez, J.M. Cepeda-Rodrigo, L. Manzano
Rev Clin Esp. 2022;222:359-69
6875
Open access
Open Article
6855
Systemic capillary leak syndrome after SARS-CoV-2 infection and after COVID-19 vaccination: A scoping review in relation to a clinical caseM. Buj, G. Morales-Varas, A. Pedrosa-Guerrero, E. Alonso-Ciria
Rev Clin Esp. 2022;222:374-6
6855
6720
Prognostic impact of metformin in patients with type 2 diabetes mellitus and acute heart failure: Combined analysis of the EAHFE and RICA registriesM. Povar-Echeverría, M. Méndez-Bailón, F.J. Martín-Sánchez, M. Montero-Pérez-Barquero, J.C. Trullàs, Ò. Miró
Rev Clin Esp. 2023;223:542-51
6720
Full text access
Open Article
6473
Performance of the case definition of suspected influenza before and during the COVID-19 pandemicE. Murillo-Zamora, C.M. Hernández-Suárez
Rev Clin Esp. 2021;221:582-6
6473
6411
Consensus on the management of hyperkalemia in patients with heart failure: Recommendations from the SEC-SEMIL. Almenar Bonet, Á. González-Franco
Rev Clin Esp. 2022;222:235-40
6411
Open access
Open Article
5910
Executive summary clinical practice guideline of postmenopausal, glucocortcioid-induced and male osteoporosis (2022 update). Spanish Society for Bone and Mineral Metabolism Investigation (SEIOMM)J.A. Riancho, P. Peris, J. González-Macías, J.L. Pérez-Castrillón
Rev Clin Esp. 2022;222:432-9
5910
Open access
Open Article
5879
Persistent COVID-19 syndrome. A narrative reviewA. López-Sampalo, M.R. Bernal-López, R. Gómez-Huelgas
Rev Clin Esp. 2022;222:241-50
5879
5593
Clinical characteristics and risk factors for mortality on admission in patients with heart failure hospitalized due to COVID-19 in SpainP. Llàcer Iborra, J. Núñez Villota
Rev Clin Esp. 2022;222:299-300
5593
5563
Assessment of frailty in the person with type 2 diabetes mellitus: Expert analysisL. Romera-Liebana, A. Urbina-Juez, R.M. Micó-Pérez, J.J. Mediavilla Bravo, A. Marco Martinez, F. Gómez-Peralta, P. Cubo-Romano, F. Formiga
Rev Clin Esp. 2023;223:552-61
5563
Full text access
Open Article
5527
Consensus document for lipid profile testing and reporting in Spanish clinical laboratoriesTeresa Arrobas Velilla, Carlos Guijarro, Raquel Campuzano Ruiz, Manuel Rodríguez Piñero, José Francisco Valderrama Marcos, Antonio Pérez Pérez, Manuel Antonio Botana López, Ana Morais López, ... en representación del Grupo Multidisciplinar de Trabajo de Lípidos y Riesgo Vascular
Rev Clin Esp. 2023;223:440-9
5527
Full text access
Open Article
5357
The impact of frailty on intra-hospital survival in older patients with COVID-19 infection: the importance of early identification. SEMI-COVID National RegistryA. López-Sampalo, H. Hernández-Negrín, M.-R. Bernal-López, M. Rubio-Rivas, M.D. Martín-Escalante, P. Wikman-Jogersen, A. García-Reyne, R. Fernández-Madera Martínez, ... R. Gómez-Huelgas
Rev Clin Esp. 2023;223:461-9
5357
Full text access
Open Article



